Arginine

Arginine

SCHEMBL4282364

N=C(N)NCCC[C@H](N)C(=O)O.O=C(O)CNC(=O)OCc1ccccc1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.55
SLC1A1 P43005 1/20 0.55
HTT P42858 1/20 0.51
DPP8 Q6V1X1 3/20 0.51
DPP7 Q9UHL4 3/20 0.51
ANPEP P15144 1/20 0.49
DPP4 P27487 2/20 0.48
DPP9 Q86TI2 2/20 0.48
FOLH1 Q04609 5/20 0.47
KEAP1 Q14145 2/20 0.46
NFE2L2 Q16236 2/20 0.46
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TGM2 P21980 1/20 0.44
PLAU P00749 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
PTGER4 P35408 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4986552 0.86 SLC1A3 (0.70) SLC1A3SLC1A1HTTDPP8DPP7
SCHEMBL2677967 0.86 SLC1A3 (0.70) SLC1A3SLC1A1HTTDPP8DPP7
SCHEMBL2037306 0.86 SLC1A3 (0.70) SLC1A3SLC1A1HTTDPP8DPP7
Hydrochloric Acid SCHEMBL6751263 0.85 SLC1A3 (0.69) SLC1A3SLC1A1HTTDPP8DPP7
Hydrochloric Acid SCHEMBL29025567 0.85 SLC1A3 (0.69) SLC1A3SLC1A1HTTDPP8DPP7
Hydrochloric Acid SCHEMBL5652476 0.85 SLC1A3 (0.69) SLC1A3SLC1A1HTTDPP8DPP7
Lysine SCHEMBL4185576 0.84 SLC1A3 (0.56) SLC1A3SLC1A1HTTDPP8DPP7
SCHEMBL3362561 0.84 DPP8 (0.50) SLC1A3SLC1A1HTTDPP8DPP7
SCHEMBL22133069 0.84 DPP8 (0.50) SLC1A3SLC1A1HTTDPP8DPP7
SCHEMBL7758995 0.84 DPP8 (0.50) SLC1A3SLC1A1HTTDPP8DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250121067-A1 WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME TRAIT BIOSCIENCES INC (US) 2025-04-17 US disclosed
US-20090299061-A1 FLUORESCENCE ASSAYS WITH IMPROVED SENSITIVITY PENN STATE RESEARCH FOUNDATION 2009-12-03 US disclosed
US-7534902-B2 Fluorescence assays with improved sensitivity WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2009-05-19 US disclosed
US-20050147997-A1 Fluorescence assays with improved sensitivity WISCONSIN ALUMNI RESEARCH FOUNDATION 2005-07-07 US disclosed
WO-2005047245-A2 FLUORESCENCE ASSAYS WITH IMPROVED BLOCKING GROUPS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2005-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050147997-A1 Fluorescence assays with improved sensitivity UACA, HNRNPUL1, FUS SLC1A3 3677/4885SLC1A1 4091/4885HTT 2179/4885
US-20250121067-A1 WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME CNR2, CNR1, BSG SLC1A3 20/4885SLC1A1 25/4885HTT 1806/4885
US-20090299061-A1 FLUORESCENCE ASSAYS WITH IMPROVED SENSITIVITY UACA, HNRNPUL1, FUS SLC1A3 3677/4885SLC1A1 4091/4885HTT 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.